ZTS Zoetis Inc.

NYSE
$71.05

Zoetis Inc. (ZTS) is confirmed to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is $1.52 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -9.9% since its last earnings release on August 6, 2026.

Zoetis Beat Expectations, Lowers Guidance
Thursday, August 6, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 7:00 AM ET
Earnings Whisper
-
vs $1.52
Rev est $2.31B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $74.69

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Zoetis Inc.

Zoetis Inc discovers, develops, manufactures & commercializes animal health medicines & vaccines for livestock & companion animals. Its products include anti-infectives, vaccines, parasiticides, medicated feed additives & other pharmaceutical products.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 14 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.